Skip to main content
. 2021 Mar 2;11(3):376. doi: 10.3390/biom11030376

Figure 1.

Figure 1

Prevalence of reduced exercise capacity, as assessed in terms of peak oxygen uptake (pVO2) of <80% of the maximum predicted in the entire hypertrophic cardiomyopathy (HCM) study sample (panel A) and dispersion of pVO2 values within the same New York Heart Association (NYHA) functional class (panel B).